RETAIL NEWS

NPAC names vice chair

BY DSN STAFF

The Neighbourhood Pharmacy Association of Canada on Monday named Karl Frank, divisional director, Bayshore Specialty Rx, as the new vice chair of the Association.

“On behalf of our board of directors and all our members and associates, I want to congratulate Karl on his appointment as vice chair,” Justin Bates, CEO Neighbourhood Pharmacies, said. “Through strong leadership from Karl and the rest of the board, we will be in the position to demonstrate pharmacy as an economic growth driver and a key part of Canada’s healthcare system.”

“I am pleased to be named by the board as the vice chair and to support the vision of Neighbourhood Pharmacies as we work towards enhancing the delivery of healthcare to Canadians through pharmacy,” Frank said. “Our members and associates look to us to provide leadership in this time of transition to become more of an integral part of the communities we serve.”

Frank has led the growth and development of Bayshore Specialty Rx and oversees the operations, including call center and patient assistance services, wholesale and a national pharmacy network as well as the national infusion clinic network and nursing services. He is also responsible for payor relationships, business development and marketing.

Prior to joining Bayshore, Frank was vice president pharmacy merchandising and operations at Loblaw. He is a graduate of the University of Alberta’s pharmacy program.

Frank was appointed by the board of the Neighbourhood Pharmacy Association of Canada at its meeting on April 6. He joined the board in 2017, and his term as vice chair will run for 1 year.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
RETAIL NEWS

Albertsons retreats on initial public offering plan

BY Marianne Wilson

Albertsons filed Friday to withdraw its plan for an initial public offering, MarketWatch reported.

The food and drug retailer withdrew its plan because of its previously announced deal to merge with Rite Aid, which was announced in February.

Albertsons said the registration statement for the IPO, which was last amended in November, had not yet been declared effective by the Securities and Exchange Commission, according to MarketWatch.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
RETAIL NEWS

McKesson leverages ePA expertise in ExpressCoverage launch

BY Michael Johnsen

ExpressCoverage is a new and powerful patient support platform launched Wednesday that connects patients, providers, payers and the life science industry to facilitate patient access and adherence for improved outcomes. The goal of ExpressCoverage is to help patients benefit from a seamless support system that improves access to medications, supports adherence and reduces prescription abandonment, ultimately resulting in better care delivery and superior patient outcomes.

“Patients are our No. 1 priority, and we are constantly looking for ways to improve their experience and access to medications, from the first discussion with their physician to the point of picking up the prescription, followed by ongoing education and adherence support,” Bill Nolan, vice president and general manager, McKesson Specialty Health, said. “The real-time connectivity between the CoverMyMeds’ network of providers, payers and pharmacies, and McKesson’s hub support services will reduce barriers to access, help patients start therapy quickly and stay on therapy longer.”

The offering is the result of a collaboration between McKesson Specialty Health, a division of McKesson Corporation, and CoverMyMeds, part of McKesson Rx Technology Solutions and a leader in electronic prior authorization solutions. Express Coverage leverages the prior authorization expertise of CoverMyMeds and the broad spectrum of high-touch biopharma-sponsored McKesson services to help physicians and patients better navigate the complexities of a specialty therapy journey.

“Prior authorization, when done manually, often results in treatment delays and gaps in therapy for patients. The prior authorization process impacts approximately 300 million prescriptions each year, and of those, roughly 36% are abandoned,” Erica Conroy, vice president operations, CoverMyMeds, said. “The integration of CoverMyMeds’ ePA solution with McKesson Specialty Health’s hub workflow helps reduce the administrative burden for providers while helping patients get the medication they need and improving outcomes.”

ExpressCoverage is part of McKesson Specialty Health’s portfolio of services for biopharma and life science companies. Leveraging proprietary technology and innovative solutions along the entire lifecycle of a drug, McKesson Specialty Health helps biopharma customers and partners bring life-changing medications to market and connect the patient to their therapies.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?